Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celldex Therapeutics Inc (NASDAQ:CLDX)

3.26
Delayed Data
As of Feb 24
 0.00 / 0.00%
Today’s Change
2.85
Today|||52-Week Range
8.75
-7.91%
Year-to-Date
3 Biotech Long Shots: Boom Or Bust?
Feb 24 / MotleyFool.com - Paid Partner Content
Looking Back at David Gardner's Worst Stock Picks of the Past 3 Years
Feb 22 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close3.26
Today’s open3.26
Day’s range3.21 - 3.31
Volume1,170,450
Average volume (3 months)2,048,536
Market cap$398.6M
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+0.76%
Earnings growth (this year)+1.53%
Earnings growth (next 5 years)--
Revenue growth (last year)+52.82%
P/E ratioNM
Price/Sales277.69
Price/Book1.11

Competitors

 Today’s
change
Today’s
% change
LNTHLantheus Holdings In...+0.60+4.98%
OXFDOxford Immunotec Glo...+0.01+0.07%
IMMUImmunomedics Inc-0.01-0.20%
VIVOMeridian Bioscience ...-0.25-1.94%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMarch 15, 2017
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$5.5M
Annual profit (last year)-$127.2M
Net profit margin-2,321.11%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Anthony S. Marucci
CFO, Secretary, Treasurer &
Senior Vice President
Avery W. Catlin
Corporate headquarters
Hampton, New Jersey

Forecasts


Search for Jobs